Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Baby formula sold at Target is recalled across the US after multistate botulism outbreak

Infant botulism is a rare but serious illness that occurs in babies under age 1

The Independent UK

Nara Organics recalls baby formula sold at Target after multistate infant botulism outbreak

Nara Organics has recalled its organic baby formula sold at Target stores and online due to a multistate outbreak of infant botulism

AAP

First-in-Class Drug Targeting Treatment-Resistant High Blood Pressure Wins FDA Approval — and Works Like No Existing Drug

FDA approved baxdrostat (Baxfendy) on May 18, 2026 as the first-ever oral aldosterone synthase inhibitor for uncontrolled and resistant hypertension. BaxHTN Phase 3 (NEJM 2025): 8.7–9.8 mmHg additional systolic blood pressure reduction added to background therapy. Here is the full story.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

How parents can talk to their kids about vaping as FDA authorizes some flavored e-cigarettes

Nearly 6% of U.S. middle and high school students vape

The Independent UK

A New Antibiotic That Defeats Superbugs Just Received FDA Approval for Dangerous Drug-Resistant Urinary Tract Infections

FDA approved Zaynich (cefepime and zidebactam) on May 29, 2026 for complicated urinary tract infections caused by drug-resistant Gram-negative pathogens. ENHANCE-1 Phase 3 trial showed superiority to meropenem at test of cure. Here is how it works and who benefits.

Medical Daily

CRISPR Gene Editing Achieves a Functional Cure for Sickle Cell Disease in 96 Percent of Patients — RUBY Trial Results in the New England Journal of Medicine Are Historic

The RUBY Trial (NEJM, April 2026): CRISPR-Cas12a gene editing therapy reni-cel (renizgamglogene autogedtemcel) achieved a functional cure in 27 of 28 (96%) severe sickle cell disease patients, with no painful crises for up to two years after treatment. Led by Dr. Rabi Hanna at Cleveland Clinic.

Medical Daily

Counterfeit Botox Injections Are Sending People to Hospitals in Multiple U.S. States — and the CDC Warns the Risk Is Ongoing

The CDC has an active warning about harmful and potentially fatal reactions from counterfeit Botox and mishandled botulinum toxin injections, documented across multiple U.S. states. A 2024 investigation found 22 hospitalizations, including 4 on ventilators. The CDC warning remains active in 2026.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Alzheimer's Disease Is No Longer Untreatable: A 2026 Guide to the Blood Tests, Drugs, and Prevention Strategies That Are Changing the Future for 7 Million Americans

A comprehensive June 2026 guide to Alzheimer's prevention and treatment: two FDA-approved disease-modifying drugs (lecanemab/Leqembi, donanemab/Kisunla), an FDA-cleared blood test (Lumipulse pTau217), and the lifestyle interventions with the strongest prevention evidence.

Medical Daily

Lassa Fever Nigeria 2026: 663 Confirmed Cases, 167 Deaths, 25 Percent Fatality Rate as US Healthcare Experts Issue Urgent Warning to Travelers

Nigeria's 2026 Lassa fever outbreak: 663 confirmed cases, 167 deaths, 25.2% case fatality rate — up from 18.5% last year — across 22 states. 39 healthcare workers infected. NETEC warns U.S. clinicians to increase suspicion in returning travelers. Here is what patients and providers need to know.

Medical Daily

ByHeart Infant Formula Botulism Outbreak Post-Investigation 2026: Root Cause Still Unidentified Despite Genetic Match to Milk Powder Supplier

The FDA and CDC declared the ByHeart infant formula botulism outbreak over on February 26, 2026 after 48 infants were sickened across 17 states. A June 10, 2026 Food Safety Magazine investigation reveals the root cause remains unidentified despite genetic matches to organic whole milk powder. New testing protocols are…

Medical Daily

AI Outpaces Trust in Healthcare as Patients and Doctors Struggle to Keep Up, 2026 Study Finds

The 2026 Future Health Index found AI is transforming clinical care, but trust gaps among doctors and patients are slowing adoption and threatening patient safety.

Medical Daily

Eli Lilly's $2.75 Billion AI Bet on Anti-Aging Drugs Signals a Major Shift in Pharmaceutical Priorities

Eli Lilly's $2.75B AI deal with Insilico Medicine targets age-related diseases. How AI is transforming longevity drug discovery and what it means for patients.

Medical Daily

FDA Clears First Human Epigenetic Reprogramming Trial in U.S. — What the Harvard-Backed Anti-Aging Therapy Could Mean for You

Harvard-backed Life Biosciences has received FDA clearance for the first-ever human epigenetic reprogramming trial. Here's what it targets and why it matters.

Medical Daily

The First Lyme Disease Vaccine in 24 Years Just Passed Its Pivotal Phase 3 Trial with 74 Percent Efficacy — and It Is for Children Too

Pfizer and Valneva announced Phase 3 VALOR trial results for Lyme disease vaccine PF-07307405 on March 23, 2026: 73.2–74.8% efficacy in ages 5 and older. Regulatory submissions planned for 2026. No Lyme vaccine has been available in the U.S. since 2002.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Frozen pizza product recalled in 21 states over possible presence of metal fragments

The US Food and Drug Administration elevated the recall to Class II, which means the product can pose a serious health risk

Medical Daily

FDA Set to Rule on First New Smoking Cessation Drug in 20 Years: Cytisinicline Decision Due June 20

Cytisinicline, a plant-based alkaloid for smoking cessation, has an FDA PDUFA date of June 20, 2026 — 8 days away. If approved, it would be the first new quit-smoking drug in 20 years. Phase 3 ORCA-2 and ORCA-3 trials showed significantly higher quit rates than placebo.

Medical Daily

Americans Are Still in Nebraska Quarantine from the Cruise Ship Hantavirus Outbreak. Here Is the Latest on the Most Unusual U.S. Health Emergency of 2026.

The CDC's June 11, 2026 situation update on the M/V Hondius Andes hantavirus outbreak: 10 Americans remain at the Nebraska Quarantine Unit, 8 have returned home for monitoring, and a separate Washington State hantavirus case has been reported. Full timeline and what it means for travelers.

The Guardian - US

Autistic children being injected with unapproved stem cell treatments supported by RFK Jr

Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

‘Autistic kids are being experimented on’: inside America’s booming market for unproven stem cell infusions

Feeling abandoned and overwhelmed, families are turning to controversial new therapies backed by the US health secretary

Bangkok Post

Instant ramen cafe raided for selling expiring, illegally imported noodles

NAKHON RATCHASIMA – A search of a popular imported instant ramen cafe in Mueang district revealed that nearly half of the store’s products were smuggled or illegally imported, lacked FDA approval and were nearing expiration.

International Business Times UK

Frozen Pizza Recall Hits 21 States as FDA Took Three Weeks to Classify Metal Risk in Popular Kids' Snack

Farm Rich Pizza Cheese Crunchers recalled in 21 states over metal pieces. The FDA took three weeks to classify the risk in the popular kids' frozen snack. Check your lot number now.

The Economic Times

Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s why

Dabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data integrity lapses. The company said the impact is limited to a small portion of operations, while broader business and domestic sales remain unaffected.

Medical Daily

A Blood Test That Detects Alzheimer's Disease Years Before Brain Scans Can Just Took a Major Leap Forward — Harvard Study Confirms It Outperforms PET Imaging in Early Detection

Harvard Mass General Brigham study in Nature Communications (April 2026): plasma pTau217 blood test detects Alzheimer's progression years before PET scans. FDA already cleared Lumipulse pTau217 test for symptomatic patients.

Medical Daily

The Antibiotic Last Line of Defense Against Gonorrhea Just Lost More Ground: WHO Data Shows Sixfold Resistance Rise and U.S. Is Running Out of Options

WHO EGASP data show ceftriaxone resistance in gonorrhea rose more than sixfold globally from 2022 to 2024. Ceftriaxone is the only U.S.-recommended gonorrhea treatment. New pipeline drugs show promise but are not yet approved.

The Economic Times

US drug regulator issues import alert for drugs made at a Dabur India plant

The US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed significant issues with data integrity and factory maintenance. Critical manufacturing records were reportedly falsified. Live birds and droppings were also found in a raw material warehouse.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

349 stories

Nature Communications

the New England Journal of Medicine

39 stories

Mass General Brigham

34 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.